Inactive Instrument

News Generex Biotechnology Corporation OTC Bulletin Board

Equities

US3714851033

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

01-19	Motion for Asset Sale Approved for Generex Biotechnology Corporation	CI
2023	Motion for Asset Sale Filed by Generex Biotechnology Corporation	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Motion for Asset Sale Approved for Generex Biotechnology Corporation	01-18	CI
Motion for Asset Sale Filed by Generex Biotechnology Corporation	11-30	CI
Motion for Asset Sale Approved for Generex Biotechnology Corporation	23-01-12	CI
Amended Bidding Procedure Approved for Generex Biotechnology Corporation	23-01-09	CI
Involuntary Petition Approved for Generex Biotechnology Corporation	22-06-06	CI
Involuntary Petition Filed Against Generex Biotechnology Corporation	22-04-23	CI
Generex Biotechnology Corporation : Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA	21-07-26	AQ
Generex Biotechnology : Material Event (Form 8-K)	21-07-23	PU
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)	21-07-23	AQ
Generex Biotechnology Corporation Enters into Quality Agreement with PPD Development, L.P	21-07-23	CI
Generex Biotechnology : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Unregistered Sales of Equity Securities (Form 8-K)	21-07-21	PU
GENEREX BIOTECHNOLOGY CORP : Unregistered Sale of Equity Securities (form 8-K)	21-07-21	AQ
Generex Biotechnology Corporation announced that it has received $1 million in funding	21-07-14	CI
NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm	21-06-22	GL
GENEREX BIOTECHNOLOGY : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-06-21	AQ
Generex Biotechnology Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021	21-06-21	CI
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)	21-05-12	AQ
Generex Biotechnology : Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services	21-05-11	AQ
Generex Biotechnology Corporation Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring Services	21-05-11	CI
Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets	21-05-10	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Generex Biotechnology Corporation OTC Bulletin Board

Equities

US3714851033

Summary

Filters